Week in Review: Keeping Patients In-The-Know

Many patients are not aware of the harmful effects that non-adherence to needed medicines can have on their health, lifestyle and the economy. This week, we explored the ways in which medication...
Read More
U.S. Trade Representative Continues the Vital IP Dialogue

Understanding how intrinsic intellectual property (IP) is to the United States economy (innovative industries support more than a quarter of all jobs in the U.S.), the Office of the U.S. Trade...
Read More
Medicare Monday: Medicare Part D & Adherence Help High Cholesterol Patients Save

According to the Centers for Disease Control and Prevention, one in three American adults has high cholesterol. For those struggling with high cholesterol, getting needed prescriptions and adhering...
Read More
India—Seizing the Opportunity

I am excited to be in India this week to discuss the scientific landscape of pharmaceutical research and development. Everywhere I go I see so much potential for India to become a leader in the...
Read More
PhRMA Foundation Launches New Web Platform

For 50 years, the PhRMA Foundation has supported young scientists in their efforts to pursue careers in research and education that will ultimately lead to improved care and treatment options for...
Read More
Medicare Monday: Managing Diabetes Thanks to Medicare Part D

Managing diabetes treatments is a big task. Medicare Part D helps patients access needed medicines, keeps costs low and helps avoid costly hospitalizations and complications. According to Betty, a...
Read More
Week in Review: Vaccine Myth Busters Edition

The internet provides us with a wealth of information right at our fingertips, but it’s important to be mindful of misinformation, especially as it pertains to your health. With myths and facts...
Read More
Health Insurance Exchange Plans Increasingly Putting Needed Medicines Out of Reach

Last year, PhRMA was joined by patient groups to highlight an analysis that found a majority of plans in health insurance exchanges required relatively high cost sharing for all medicines in at least...
Read More
PhRMA Salutes Outgoing FDA Commissioner’s Leadership, Looks Forward to Continued Collaboration

Last week, Food and Drug Administration (FDA) Commissioner Margaret Hamburg announced that she will step down from her post at the end of next month.
Read More
Medicare Monday: Congestive Heart Failure Patients Benefit From Taking Advantage of Part D

When a Medicare Part D beneficiary adheres to their prescription regimen, both the individual and the broader health care system benefit. The Congressional Budget Office (CBO), for example, now...
Read More
New Report: Forecasts for Specialty Medicines Have Been Overstated
By Jennifer Bryant | February 9, 2015
According to a new report from actuaries Gabriela Dieguez, Bruce Pyenson and Jennifer Carioto, at Milliman, major pharmacy benefits managers (PBMs) often overestimate future spending on specialty...
Read More
Week in Review: Continued Progress for Patient Health

In recent years, the development of new medicines has helped transform the lives of patients. But lives cannot be improved without access to those innovative treatments. We support helping patients...
Read More
New Analysis: Midyear Formulary Changes in Marketplace Plans Can Significantly Reduce Access to Needed Medications for Patients

Did you know health insurance exchange plans are allowed to drop coverage of medications from their formularies midyear? Early evidence indicates that some health insurance exchange or marketplace...
Read More
World Cancer Day: Revolutionizing Treatment for Patients is “Not Beyond Us”

Today is World Cancer Day, and 2015’s “Not beyond us” theme highlights an incredibly important message: we’re making tremendous advances in the fight against cancer and continued progress means a...
Read More
Maintaining Appropriate Incentives for Biopharmaceutical Innovation

As we enter the second half of the decade, the biopharmaceutical industry’s approach to research and development (R&D) continues to evolve to meet the growing demand for new medicines. New research,...
Read More
Why the World Looks to the U.S. for the Most Elusive Cures

Research and development (R&D) is the backbone of the biopharmaceutical industry and the reason why we have seen more than 450 new medicines approved in the U.S. since 2000 to help fight cancer,...
Read More
Medicare Monday: Providing Value to Beneficiaries

Medicare Part D is an incredibly important and successful program that provides seniors and persons with disabilities with access to affordable prescription drug coverage. While recent surveys...
Read More